MARY TILLOTSON: Open Payments
NPI 1780284869 · NIAGARA FALLS, NY. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$2,055 in 96 payments from 11 companies in 2025. Trend: 2023 $1,901 · 2024 $2,037 · 2025 $2,055
Food & beverage: $2,050Education: $5
| Company | Payments | Amount |
|---|---|---|
| Neurocrine BioSciences, Inc. | 13 | $336 |
| E.R. Squibb & Sons, L.L.C. | 15 | $327 |
| Vanda Pharmaceuticals Inc. | 13 | $305 |
| Teva Pharmaceuticals USA, Inc. | 18 | $289 |
| Axsome Therapeutics, Inc. | 5 | $212 |
| Otsuka America Pharmaceutical, Inc. | 11 | $204 |
| Janssen Pharmaceuticals, Inc | 12 | $198 |
| Alkermes, Inc. | 5 | $111 |
| ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | 2 | $43 |
| Luye Pharma (USA) Ltd. | 1 | $16 |
Products named: INGREZZA, COBENFY, FANAPT, UZEDY, INVEGA SUSTENNA, ABILIFY ASIMTUFII, ARISTADA, AUSTEDO XR.
Industry payments across NY — which companies pay providers there.
